Cytokines induce nitric oxide synthesis by endothelial ceils, macrophages and polymorphonuclear leucocytes, indicating a role for nitric oxide in inflammatory processes. Nitric oxide production was therefore measured indirectly as nitrite in serum and synovial fluid samples from patients with rheumatoid arthritis (RA) and osteoarthritis (OA) together with serum samples from healthy volunteers matched for age and sex. Serum nitrite concentrations in patients with RA and OA were significantly higher than in controls. In both disease groups synovial fluid nitrite was significantly higher than serum nitrite, implying nitric oxide synthesis by the synovium. Serum and synovial fluid nitrite concentrations in RA were also significantly higher than those in OA. These data show increased nitric oxide production in RA and OA and suggest a role for nitric oxide as an inflammatory mediator in rheumatic diseases.
Nitric oxide has been shown to be the endothelium derived relaxing factor.' It is synthesised by the vascular endothelium from L-arginine and interacts with the haem group of guanylate cyclase to increase cGMP formation in vascular smooth muscle cells. Altered nitric oxide synthesis may affect the pathogenesis of some cardiovascular diseases.2 The L-arginine to nitric oxide biosynthetic pathway has also been identified in numerous other cells and tissues including the adrenal glands,3 brain,4 5 platelets, 6 and some non-adrenergic non-cholinergic nerve terminals,7 suggesting a more widespread role for nitric oxide in the regulation of cellular function and communication. 2 In all these cells nitric oxide is synthesised by a constitutive Ca2" calmodulin dependent nitric oxide synthase.8 Nitric oxide is also generated by macrophages,9 polymorphonuclear leucocytes, I' lymphocytes," and hepatocytes,'2 though in these cells an inducible enzyme is responsible for its synthesis. This enzyme is not Ca2+ dependent, is induced by cytokines,8 13 14 and its induction is inhibited by glucocorticoids.8 Moreover, its expression results in the sustained release of nitric oxide in amounts far in excess of those by the constitutive pathway. This enzyme was originally described in macrophages in which nitric oxide is essential for cytotoxicity against tumour cells and protozoa.9 14 The latter may require an interaction of nitric oxide with the superoxide anion, ' There was no significant loss of nitrite from samples following freeze/thawing or storage at -70°C for up to six months. After 15-18 months storage at -70°C the mean nitrite loss from samples was 11%.
Statistics
The results in the patient and control groups were normally distributed and were analysed by Student's t test. Correlation data were analysed using Kendall's rank correlation method. The study was performed with local ethical committee approval and in accordance with the articles ofthe Helsinki declaration.
Results

Mean nitrite concentrations in synovial fluid
and serum samples were in the ltmol/l range (see table) . The nitrite concentration in serum samples from patients with RA was over twice that of serum samples from patients with OA (p<0005). It was also three times that of controls matched for #ge and sex (0-44 and 0-147 pmol/l respectively, p<0-001) (figure).
The serum nitrite concentration in patients with OA was also higher than that in controls matched for age and sex (0-213 and 0-142 ,umol/l respectively; p<005).
The mean nitrite concentration in synovial fluid in patients with RA was 0-91 .tmol/l, which was over twice the 0A44 iimol/l in serum samples (p<001). The inducible nitric oxide pathway plays a part in inflammatory disorders. The most intriguing finding was that serum nitrite concentrations were increased in patients with RA and OA compared with controls matched for age and sex. The origin of this nitrite is not clear; widespread synovial inflammation might increase serum nitrite when synovial fluid cleared by the lymphatic system enters the systemic circulation and by equilibration with the vascular compartment within the synovium. This may not entirely account for the higher serum nitrite concentration in RA compared with controls, however, and seems an unlikely explanation in patients with OA. A possible source of increased nitrite is the systemic vasculature and other cells in which the induction of nitric oxide has been shown. Although difficult to reconcile with current concepts of OA, this is compatible with the systemic nature of RA, in which circulating cytokines are evident23 and in which vasculitis is a common complication. The precise part played by nitric oxide in inflammation remains to be elucidated. Actions of nitric oxide relevant to this process include its role in the cytotoxic mechanism ofactivated macrophages,9 inhibition of iron-sulphur centred enzymes24 and its antiproliferative effects. 25 26 Nitric oxide is also implicated in chemotaxis of polymorphonuclear leucocytes,27 and L-arginine, the precursor of nitric oxide, has been shown to have in vivo immunoregulatory actions. The latter include enhanced wound healing and T cell function,28 notably increased natural and lymphokine activated killer cell activity. 29 The powerful vasodilating' and platelet inhibitory6 actions of nitric oxide are also pertinent to rheumatoid synovitis. Microvascular injury is prominent in the latter and includes thrombus plugging and features typical of hypoxia.30 Evidence suggests that the latter is due to hypoxic reperfusion injury consequent on impaired synovial perfusion during joint exercise. 19 In this situation nitric oxide induced vasodilatation and the removal of superoxide by reaction with nitric oxide might be protective. In vitro, however, the latter reaction yields hydroxyl radicals via the peroxynitrite anion. 6 17 If the latter occurs to a considerable degree in vivo it may far outweigh the favourable actions of nitric oxide with the net effect of increasing microvascular and synovial tissue injury.
Further investigation is required to establish whether the overall effect of nitric oxide generated by the inducible enzyme is proinflammatory. There is clear evidence that induced nitric oxide synthesis leads to cellular injury,3' which is inhibited by glucocorticoids.8 3' The latter occurs at glucocorticoid concentrations within the therapeutic range and appears to be specific as the inhibitory effect is blocked in a concentration dependent manner by cortexolone, a partial agonist ofglucocorticoid receptors. 8 We have shown highly significant differences between nitrite concentrations in synovial fluid and serum samples and in serum samples from patients with RA and OA compared with controls matched for age and sex. This suggests increased endogenous nitric oxide synthesis in these rheumatic diseases and nitric oxide production by the synovium and probably other tissues. It is likely that increased nitric oxide production may play a part in the pathogenesis of these and other diseases in which cytokines have been implicated. Nitrite provides a measure of endogenous nitric oxide synthesis and this study shows that nitrite may be measured in samples from humans without complex preparatory steps. These results should encourage other workers to use nitrite concentrations to examine alterations of nitric oxide biosynthesis in other diseases.
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